Investigation of Early Hormonotherapy Efficacy of Prostate Cancer

• Status: Unknown status
• Trial end date: 2020-01-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to determine whether early hormonotherapy is effective in the treatment of high risk prostate cancer patients after radical prostatectomy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kaunas University of Medicine
• Treatments: Triptorelin Pamoate

Criteria

Inclusion Criteria:

• preoperative PSA>20ng/ml

• postoperative PSA >0.2 ng/ml

• Gleason > 7

• pT3b

• signated infomed consent

Exclusion Criteria:

• neoadjuvant hormonaltherapy before RP

• R1 RP

• N+ RP

• unstable cncomitant conditions